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membranes has high potential for enabling understanding of the structure-function relationship in antimicrobial and cell-pene-
trating peptides. We have applied a combined imaging strategy to track the interaction of a model antimicrobial peptide, PFWRIR-
IRR-amide, with bacterial membrane-mimetic supported phospholipid bilayers comprised of POPE/TOCL. Our in situ studies
revealed rapid reorganization of the POPE/TOCL membrane into localized TOCL-rich domains with a concomitant change in
the organization of the membranes themselves, as reﬂected by changes in ﬂuorescent-membrane-probe order parameter,
upon introduction of the peptide.INTRODUCTIONThe ability of short cationic peptides to penetrate cell
membranes has led to significant interest in their use as anti-
microbial (AMPs) and cell-penetrating agents. Most AMPs
are expressed from genes involved in the innate defense of
various organisms and are capable of preventing the invasion
of pathogenic microorganisms (1). The apparent inability of
bacteria to develop resistance to these systems makes them
attractive therapeutic candidates (2). Understanding the
link between the structure and mechanisms of action of these
peptides is therefore of particular interest for the de novo
design of targeted AMPs. Most AMPs are believed to cause
membrane permeabilization through one of three possible
routes: carpet (3), barrel-stave pore (4), or toroidal pore
(5), although other mechanisms that do not involve perfora-
tion may exist, including membrane crowding. Identifying
whether the AMPs target specific membrane components
and whether they themselves induce specific restructuring
of the membrane is of particular interest. Although lateral
inhomogeneities commonly referred to as membrane
domains are recognized to exist in mammalian systems,
recent evidence has suggested that similar structures also
exist in bacterial membranes (6–16). Moreover, there is
increasing evidence that the efficacy of some cationic antimi-
crobial agents is determined by their effects on membrane
domains (17–25). To date, evidence of such phenomena,
which may include clustering of the cationic antimicrobial
peptide with certain anionic lipids, has been obtained from
differential scanning calorimetry, nuclear magnetic reso-
nance, and freeze-fracture microscopy studies (17,19–21).Submitted October 22, 2009, and accepted for publication December 9,
2009.
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0006-3495/10/03/0815/9 $2.00We previously used simultaneous correlated in situ atomic
force (AFM) and fluorescence microscopy to investigate
peptide-membrane interactions using substrate-supported
phospholipid bilayers (SPBs) as membrane-mimetic sub-
strates (26–28). Coupling these imaging modalities for the
study of SPBs provides an effective means of overcoming
the key limitations of the individual techniques. For
example, AFM is well suited for resolving molecular-scale
topographical details at surfaces; however, it is limited in
its ability to image structures that do not provide sufficient
topographical contrast, such as peptides that have inserted
into a membrane. AFM, as conventionally practiced, also
lacks chemical specificity and thus one often identifies struc-
tures solely based on size and shape. Conversely, optical
microscopy has traditionally been a diffraction-limited tech-
nique, relying heavily on the use of fluorescent reporter
molecules. With a hybrid scanning probe-optical imaging
system, complementary information is acquired by both
techniques and can be spatially correlated to provide a clearer
picture of molecular-level peptide-membrane interactions
(29–32). Furthermore, differences in optical properties
such as emission wavelength (33–38), fluorescence lifetime
(39–41), or, as we report here, the linear dichroism/polariza-
tion anisotropy (42–48) of the reporter fluorophores, can be
exploited to obtain additional quantitative and dynamic
insights into the environment surrounding the probe (49).
The temporal resolution of optical imaging and spectroscopy
is also a clear advantage over the slower raster-scanning
AFM. Using polarized total internal reflection fluorescence
microscopy (pTIRFM), an orientational order parameter,
hP2i, can be calculated that reflects the time- and
ensemble-averaged orientational order of a collection of
fluorescent probe molecules (47,50–54), in direct analogy
to that reported by other orientation-sensitive spectroscopies
(55–58). This approach allows one to create spatial maps ofdoi: 10.1016/j.bpj.2009.12.4327
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image hP2i that, in a coupled AFM-fluorescence system,
can then be correlated against specific topographical
features. Spatio-temporal changes in hP2i can be used to
examine time-dependent orientational order changes in the
environment surrounding the fluorescent probes. Such
changes may arise from alterations to the local membrane
composition, domain restructuring, and membrane remodel-
ing, or through the action of enzymes or peptides that specif-
ically interact with membrane components.
Our earlier studies of the model antimicrobial peptide
indolicidin (47,59), prompted us to apply these tools to char-
acterize the interactions of a model small cationic peptide,
PFWRIRIRR-amide (PR-9), that has shown potent antimi-
crobial activity only against Gram-positive bacteria that
contain neutral or zwitterionic lipids as well as anionic lipids,
suggesting a role for the clustering of anionic lipids by this
agent (R. F. Epand and R. M. Epand, unpublished work).
Upon interaction with model SPBs containing cardiolipin
and phosphoethanolamine, our studies revealed that PR-9
induces the formation of cardiolipin-rich domains with
a concomitant reduction in the ordering of the lipid acyl tails.
This remodeling effect results in structural instabilities in the
model membranes, consistent with recent studies suggesting
phase separation as an alternative mechanism of antimicro-
bial peptide action (16,19,60).FIGURE 1 Chemical structures of the synthetic lipids and fluorescent
membrane probes used in this study. (A) POPE, (B) TOCL, (C) NAO, and
(D) DiI-C20. The shaded double arrows in panels C and D indicate the
approximate orientation of the main electronic transition dipole moment
with respect to the chromophore structure of the fluorescent probe.MATERIALS AND METHODS
Materials
The synthetic lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanol-
amine (POPE, 16:0–18:1) and 10,30-bis[1,2-dioleoyl-sn-glycero-3-phospho]-
sn-glycerol (TOCL, 18:1), along with beef heart cardiolipin, were purchased
from Avanti Polar Lipids (Alabaster, AL) and used without further purifica-
tion. Two mg (total) of POPE and TOCL lipids in a 3:1 molar ratio were
dissolved in 2:1 chloroform/methanol (v/v) and transferred into a clean glass
centrifuge tube. The solvent was removed under a stream of nitrogen gas and
then placed in a vacuum desiccator for 3 h. The dried lipid film was then
sealed under Argon gas and stored at 20C. The fluorescent lipophilic
probes 10-nonyl-acridine orange (NAO) and 1,10-di-eicosanyl-3,3,30,30-
tetramethylindocarbocyanine perchlorate (DiI-C20) were purchased from
Invitrogen/Molecular Probes (Oakville, Ontario, Canada) and Molecular
Targeting Technologies (West Chester, PA), respectively, dissolved in
pure ethanol at a concentration of 0.5 mg/mL and stored in glass vials at
4C capped under nitrogen gas. The chemical structures of the lipids and
fluorescent probes used in this study are shown in Fig. 1. The antimicrobial
peptide, PFWRIRIRR-amide (PR-9), synthesized with C-terminal amidation
and purified to>95%, was purchased from SynBioSci (Livermore, CA). The
PR-9 peptide was dissolved at a concentration of 1.34 mg/mL in pH 7.4
PIPES aqueous buffer (20 mM PIPES, 140 mM NaCl, 1 mM EDTA)
prepared using ultrapureMilli-Qwater (Millipore, Billerica,MA), and subse-
quently stored in a glass vial at 20C. Before use, the stock AMP solution
was gently warmed up to room temperature and vortexed for 5 s.
Substrate-supported lipid bilayer formation
SPBs composed of 3:1 POPE/TOCL were created by the method of vesicle
fusion (61–63). First, small unilamellar vesicle (SUV) suspensions were
prepared by rehydrating the 3:1 POPE/TOCL lipid films with pH 7.4 HEPESBiophysical Journal 98(5) 815–823aqueous buffer (10 mM HEPES, 150 mM NaCl) to concentration of ~1 mM
and sonicating at 50C for 20 min. SUV suspensions were stored at 4C in
1.5-mL plastic microfuge tubes for up to one week. On the day of a
pTIRFM/AFM imaging experiment, 3:1 POPE/TOCL substrate-supported
phospholipid bilayers (SPBs) were prepared by sequentially depositing
100 mL of the SUV suspension and 2.9 mL of pH 7.4 aqueous HEPES buffer
onto freshly cleaved mica (Structure Probe, West Chester, PA) affixed to a
170-mm-thick, 50-mm-diameter glass-bottom culture dish (WillCoWells,
Amersterdam, The Netherlands), with optical adhesive #63 from Norland
Products (Cranbury, NJ). A detailed protocol describing the construction
of mica-glass substrates for SPB imaging experiments has been reported
Peptide-Induced Domain Formation 817previously (64). After standing at room temperature for 15 min, the sample
chamber was washed 10 times with 1-mL aliquots of HEPES buffer to either
remove excess SUVs in solution or prevent them from adhering to the
bilayer surface, ensuring the total solution volume in the chamber was
3 mL at all times. In most experiments, the upper leaflet of the SPBs (i.e.:
the leaflet furthest away from the supporting substrate) was labeled with
the fluorescent lipid probes NAO or DiI-C20 using the following protocol.
The fluorescent lipid probes in ethanol were diluted 1000-fold in pH 7.4
HEPES buffer and 25 mL of the solution then injected into the sample
chamber after removal of 25 mL of the chamber solution. After gentle
flushing with 3 mL of HEPES buffer, the sample chamber was attached to
the microscope stage using custom magnetic holders.
Combined pTIRFM/AFM imaging
The combined pTIRFM/AFM instrument and its use for SPB imaging was
recently reported by us (47,65). In brief, the AFM raster-scans over the upper
surface of the SPB, generating a topographical image with subnanometer
vertical resolution and nanometer lateral resolution. Depending on the
bilayer composition and imaging conditions, lipid domains may be resolved
as local variations in bilayer thickness arising from differences in acyl-chain
packing (66–71). In pTIRFM, a polarized beam of light is directed through
the periphery of a high-numerical-aperture microscope objective lens such
that the beam undergoes total internal reflection at the substrate-sample solu-
tion interface. The resulting surface-traveling evanescent wave penetrates
~250 nm or less into the sample. Fluorescence-detected linear dichroism
images of a fluorescently labeled SPB are acquired by capturing images
with an electron-multiplying charge-coupled device (EMCCD) camera
under equal intensity substrate perpendicular (p-polarized) and substrate
parallel (s-polarized) excitation. A right-handed sample coordinate system
is defined with the z direction normal to the substrate interface (parallel to
the microscope objective optical axis), and the x direction oriented along
the direction of travel of the evanescent field wavefront at the substrate-
solution interface. Under uniaxial symmetry, as is usually the case for flat
SPBs, the pTIRFM order parameter (originally derived by Thompson
et al. (51) using a semiclassical treatment of light-matter interactions),
hP2i, can be calculated on a per-pixel basis using the equation
hP2i ¼ Ix  R
FDIy þ Iz
Ix  RFDIy þ 2Iz; (1)
where Ix, Iy, and Iz are the squares of the x-, y-, and z-direction evanescent
electric-field vector amplitudes, respectively, calculated using the Fresnel
equations of physical optics when the angle of incidence (a) of the illumi-
nating TIRF beam and the relative index of refraction (n ¼ n1/n2) between
the mica substrate (n2) and the sample solution (n1) are known (51,72).
The fluorescence-detected dichroic ratio, RFD, is the ratio of the fluorescence
intensity values (F) for a region of interest (ROI) under total internal reflec-
tion illumination with p-polarized and s-polarized excitation light,
RFD ¼ Fp
Fs
; (2)
and is analogous to the absorption dichroic ratio reported in polarized atten-
uated total internal reflection Fourier transform infrared spectroscopy
(57,58,73,74). The RFD image is generated by pixelwise division of the Fp
and Fs images. Because the R
FD image is a ratio of two images captured
under different illumination polarizations, factors that affect the absolute
fluorescence intensity, such as local probe concentration and quantum yield,
cancel out (50,54). The RFD image thus reflects only molecular factors that
affect the orientational order of the probes within a given pixel. The pTIRFM
order parameter hP2i image is calculated by applying Eq. 1 at every pixel in
the RFD image. If the angle of incidence of the illuminating TIR beam is set
to the critical angle (a ¼ ac) of the substrate-solution interface, the illumi-
nation beam travels horizontally and parallel to the interface, and the x
component of the evanescent electric-field vector vanishes (Ix/0). Equa-
tion 1 then assumes the following simpler and more compact form,hP2i ¼ Iy  GIz
I þ 2GI ; (3)y z
where G ¼ 1/RFD. A common interpretation of hP2i is that it is the first
nontrivial term in an infinite series expansion of Legendre polynomials
that describe the fluorescent probe’s orientation probability distribution
function (75)
hP2i ¼ 3cos
2hqi  1
2
; (4)
where q is the polar tilt angle that the fluorescent probe’s absorption transi-
tion dipole moment makes with the substrate normal. The angled brackets
around q denote an ensemble average over all fluorescent molecules within
the detection volume and over the timescale associated with light absorption.
It is important to note that order parameter measurements by an orientation-
sensitive technique such as pTIRFM only partially characterize the true
probe-orientation-distribution function. Although other models of the phys-
ical interpretation of hP2i are possible, their limitations are discussed in
Oreopoulos and Yip (47) and references contained therein.pTIRFM/AFM imaging protocol
The pTIRFM/AFM imaging protocol of a 3:1 POPE/TOCL SPB was as
follows: an ROI of a SPB labeled with NAO or DiI-C20 was brought into
focus under total internal reflectance illumination. The EMCCD camera
exposure time was set at 200 ms and the multiplication gain set to 3500.
The pTIRFM polarization angle (p- or s-polarization) that yielded maximal
fluorescence intensity was identified by inspection and viewed in the camera
software’s preview mode. The incident-excitation beam laser power was
adjusted (0.25–0.50 mW) such that this image’s brightest feature pixel-
intensities were just below the camera’s 16-bit linear-dynamic-range satura-
tion level with the camera exposure and gain sensitivity levels held constant.
The p- and s-polarized pTIRFM images were sequentially acquired at these
laser power and camera settings. Immediately after pTIRFM image capture,
the prealigned AFM was engaged to the sample surface and a 20  20 mm
AFM image of the central area within the same TIRF-illuminated ROI was
acquired.
The microscope was then switched back to pTIRFM imaging mode and
the EMCCD multiplication gain increased to 3900. The illumination laser
power was reduced such that the pixel intensities in the camera software
preview mode were below saturation. A 30-mL aliquot of PR-9 dissolved
in PIPES buffer solution was injected into the sample chamber while simul-
taneously acquiring time-lapse pTIRFM images (200-ms exposures,
750 frames; p-polarization for NAO, s-polarization for DiI-C20). Three
different AMP aliquot stock concentrations were tested: (I) 1.34 mg/mL;
(II) 0.67 mg/mL; and (III) 0.20 mg/mL. Because the total sample volume
was maintained at 3 mL, the final diluted AMP concentrations in the sample
imaging chamber were: (I0) 13 mg/mL; (II0) 6.7 mg/mL; and (III0) 2.0 mg/mL.
After the time-lapse pTIRFM image acquisition, the same combined
pTIRFM/AFM image series described earlier was acquired on the same
ROI. If significant photobleaching occurred during time-lapse pTIRFM
imaging, a different ROI of the same sample was randomly selected and
examined using the same combined imaging procedure.
In a separate series of experiments, unlabeled SPBs composed of 3:1
POPE/TOCL were imaged by time-lapse AFM alone. First, five different
20 mm  20 mm ROIs were scanned before adding the 30-mL aliquot of
the AMP at concentrations I, II, or III. After acquiring the fifth image, the
AMP aliquot was injected into the imaging chamber shortly after the repeat
scan of the same ROI. If possible, the same ROI was imaged continuously
for a maximum of 120 min. If AFM tracking was lost during this time, a
randomly selected ROI in the same sample was imaged for the duration of
the time.
All AFM images were obtained using tapping-mode in aqueous pH 7.4
HEPES buffer using short-thin 125-mm V-shaped DNP-S tips (Nanoprobes,Biophysical Journal 98(5) 815–823
818 Oreopoulos et al.Veeco, Santa Barbara, CA) driven at a tip oscillation frequency of ~8.5 kHz,
and a drive amplitude setpoint of 0.3–0.2 V using a Digital Instruments/
Veeco Bioscope scanning probe microscope equipped with a dual-range G
scanner and interfaced with a Nanoscope IIIA controller (Veeco Metrology,
Santa Barbara, CA). All AFM images were acquired using Nanoscope soft-
ware (Ver. 5.30r1) as 512  512 pixel images at a scan rate of 1 Hz (Digital
Instruments, Gujarat, India). All pTIRFM images were acquired on a home-
built free-space three-laser TIR illumination system constructed around an
IX-70 inverted microscope using a PLAN-APO 60 1.45 numerical-aper-
ture microscope objective (Olympus, Center Valley, PA) and a Cascade II
512B EMCCD camera (512 512 pixels, 16 16 mm pixel size; Photomet-
rics, Tucson, AZ) (47). Polarization optics were inserted into the excitation
path of the optical train and allowed the illuminating light’s polarization
angle to be switched between p- and s-polarized. For these studies, NAO
and DiI-C20 excitation was provided by a 532-nm diode pumped, solid-state
laser. Fluorescence was viewed through a filter cube outfitted with a 565-nm
dichroic mirror and a 565–605-nm emission bandpass filter. The polarization
extinction ratio was measured to be 127:1 at the objective (72). The pTIRFM
images were captured using the open-source camera driver software mMan-
ager (Ver. 1.2.32, (76)). The EMCCD camera was shut off during AFM
imaging to avoid vibration artifacts caused by the camera’s cooling fan.
All experiments were performed at room temperature.
pTIRFM/AFM image postprocessing
All AFM images were subjected to a zero-order flattening and an x-axis
second-order plane-fit filter using Digital Instruments/Veeco Nanoscope
software (Ver. 30r1). Height-line-profile analyses were performed using
the Nanoscope software’s Section Analysis tool. The p- and s-polarized
pTIRFM intensity images are presented in grayscale with equal brightnessBiophysical Journal 98(5) 815–823and contrast settings within each pTIRFM/AFM image set. The pTIRFM
order parameter images were calculated using an in-house-written NIH Im-
ageJ (http://rsb.info.nih.gov/ij/, Ver. 1.43e) macro that is available upon
request. Using the two Fp and Fs pTIRFM images, the total internal reflec-
tance illumination beam angle of incidence (a), and the substrate/buffer
solution relative index of refraction (n) as inputs (a ¼ 60; n ¼ 0.84 corre-
sponding to Iy ¼ 3.95 and Iz ¼ 5.49), the macro subtracts the background
from each image and determines the RFD image by pixelwise division. For
each pixel, hP2i was evaluated using Eq. 3 and plotted as a new 32-bit
floating-point value image. The resulting order parameter image was then
color-coded using ImageJ’s ‘‘Fire’’ look-up table. The look-up table contrast
was stretched to cover the full range of hP2i values in the order parameter
images, both before and after the addition of the AMP. To illustrate the
distribution and range of hP2i values obtained for each case, one-dimen-
sional image histograms were computed and presented with the order param-
eter images. Statistical analysis of the order parameter images was carried
out using ImageJ’s built-in image threshold and measure functions. The
time-lapse pTIRFM image sequences were analyzed using ImageJ’s built-
in particle analysis functions.RESULTS
Lipid bilayers formed by direct fusion of 3:1 POPE/TOCL
vesicles on mica and subsequently labeled with NAO ex-
hibited uniform fluorescence and topography when examined
by correlated pTIRFM/AFM (Fig. 2, A–D). We did not
observe any phase separation or domains before addition of
the PR-9 peptide. Close inspection of smaller 1 mm  1 mmFIGURE 2 Combined pTIRFM/AFM image set of the
same 20  20-mm ROI of a 3:1 POPE/TOCL SPB fluores-
cently labeled with NAO before and after the addition
of PR-9 (image chamber concentration of 6.7 mg/mL).
(A, B, E, and F) The p-/s-polarized pTIRFM images of
the sample before and after the addition of the peptide,
respectively. These intensity images are presented with
equal contrast settings. (C and G) Calculated pTIRFM
order-parameter images of the sample before and after
the addition of the AMP. The image contrast of the two
order-parameter images is stretched to cover the full range
of hP2i pixel values present in both images. (D and H)
Corresponding AFM images of the SPB before and after
the addition of the AMP. The star symbols (*) in panels
E–H are meant as guides for the reader’s eye to identical
xy locations in the after-peptide-addition images.
Scale bar ¼ 5 mm.
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suboptical diffraction-limit-sized or topographically distinct
domains (see Fig. S1 in the Supporting Material). As NAO
is known to associate with TOCL (7,77), the uniform fluores-
cence in the Fp and Fs pTIRFM images suggests that the
TOCLwas evenly mixed with the POPE lipids before peptide
addition. The corresponding pTIRFM order parameter
images were similarly uniform, exhibiting a normally distrib-
uted pixel-average hP2i value of 0.155 0.01, measured over
several ROIs and replicate samples (Fig. 2 C).
Having established the baseline fluorescence and topog-
raphy of the 3:1 POPE/TOCL bilayers in the absence of
PR-9, we then examined how the physical state of the bilayer
was altered upon exposure to PR-9. Three different PR-9
concentrations were tested and time-lapse pTIRFM images
of SPBs fluorescently labeled with NAO were captured as
a small aliquot of the peptide was injected into the sample
chamber. (See Movie S1, Movie S2, and Movie S3 in the
Supporting Material.) Upon introduction of PR-9 at a sample
chamber concentration of (I0) 13 mg/mL, bright spots ranging
in size from diffraction-limited spots to a few micrometers in
diameter rapidly appeared (transition from one 200-ms frame
to the next, 0.6 s after the initial peptide aliquot injection).
At lower peptide concentrations of (II0) 6.7 mg/mL and (III0)
2.0 mg/mL, the same phenomena were observed although the
time required for the spots to appear was significantly longer,
~3.2–7.8 s after introduction of the peptide. The rapid nucle-
ation and growth of these spots at the higher peptide concen-
trations (I0, II0) precluded stable imaging and analysis. It was
only at the lowest peptide concentration (III0) that the nucle-
ation and growth of these bright spots could be reliably
monitored and analyzed (Fig. 3). Here we found that the
areal growth rate of the larger spots was ~1.0–3.0 mm2/s
(Fig. 3, B and C). Smaller spots that were equal to or just
over the diffraction limit of detection appeared 15–20 s after
the initial nucleation of the larger spots. On rare occasions,some spots shrank slightly in size over time; however, the
general trend was for stable growth.
To determine whether the pTIRFM-resolved bright spots
seen after PR-9 peptide addition were laterally phase-sepa-
rated lipid domains, we examined the matching AFM
images, finding that the bright areas corresponded to topo-
graphically distinct rounded domains that extended ~3.0–
3.5 nm above the surrounding contiguous phase (Fig. 2,
E–H). The AFM images were also populated by numerous
smaller ~100–500-nm diameter circular structures that
were well over 35 nm in height with respect to the membrane
surface. These features were located on top of both the
domains and the surrounding lower topography lipid phase.
We were unable to resolve any finer topographical structures
(i.e., structured/oriented protein aggregates) within the
domains or the surrounding contiguous phase by AFM.
The calculated pTIRFM order parameter images of the 3:1
POPE/TOCL SPBs after PR-9 exposure revealed a spatially
heterogeneous distribution of hP2i values (Fig. 2 G). The
bright spots in the pTIRFM images corresponding to the
taller/higher domains resolved by AFM had a slightly lower
hP2i value than the surrounding lower topography contig-
uous lipid phase. Using image intensity thresholding and
Gaussian decomposition, the image histograms of these
order parameter images could be fit by two normal distribu-
tions. The bright domains exhibited a hP2ihigh value¼ 0.125
0.01, whereas the rest of the order parameter image had a
hP2ilow value ¼ 0.185 0.02.
We also used pTIRFM/AFM to examine 3:1 POPE/TOCL
SPBs labeled with the fluorescent lipid DiI-C20, both before
and after addition of PR-9. DiI-C20 is known to preferentially
partition into more ordered phases in model membranes
(78–82) and its orientational order in SPBs and giant unila-
mellar vesicles has been characterized previously by fluores-
cence polarization microscopy (47,53,83). As in the case of
NAO, the DiI-C20 fluorescence was initially uniformlyFIGURE 3 Time-lapse pTIRFM
image sequence of a 3:1 POPE/TOCL
SPB fluorescently labeled with NAO
as PR-9 is introduced into the imaging
chamber at a final concentration of
2.0 mg/mL. (A) Selected time-stamped
frames from the entire sequence are
presented. The PR-9 aliquot is injected
into the sample chamber at frame 50
(t ¼ 10 s). Several bright spots (labeled
a–d) that emerge during the sequence
are indicated. Scale bar ¼ 5 mm. (B)
Plot of bright spot area versus time.
(C) Enlarged plot of the shaded region
in (B) showing that the initial growth
of the larger spots in panel A (spots
a and b) proceeded at different rates.
Biophysical Journal 98(5) 815–823
820 Oreopoulos et al.distributed laterally in 3:1 POPE/TOCL SPB; however, upon
PR-9 addition, diffraction-limited and larger micrometer-
sized brighter spots of DiI-C20 fluorescence could be seen
throughout the bilayer. The average pTIRFM order parame-
ters associated with both the DiI-C20 and NAO labels are
summarized in Table 1. To discount the possibility that
domain formation was an artifact arising from photooxida-
tion of the fluorescent probe (84–86), we monitored the
effect of PR-9 on unlabeled 3:1 POPE/TOCL SPBs by
AFM alone, finding similar domain formation upon peptide
addition (Fig. 4).DISCUSSION
Recent work by us and others has suggested that phase sepa-
ration and/or domain formation may be an alternative mech-
anism of action for certain antimicrobial peptides that
directly contrasts with the more conventional models of
AMP activity (16,19,22,60,87–90). Using a correlated
imaging approach, we have examined the interaction of the
model cationic AMP PR-9 with model 3:1 POPE/TOCL
SPBs intended to mimic the inner membrane of E. coli and
many other bacterial species with high phosphoethanolamine
content. Using NAO as a fluorescent probe because of its
known association with cardiolipin in both model and real
cell membranes (7,12,77,91–93), our combined pTIRFM/
AFM fluorescence measurements suggest that TOCL was
homogenously distributed in the SPB before exposure to
PR-9. Moreover, our data suggested that the absorption tran-
sition dipole moment of NAO was, on average, tilted ~49
with respect to the membrane normal. As the orientation of
NAO in membrane bilayers has not been previously charac-
terized by pTIRFM experiments or any other orientation
sensitive spectroscopic methods, we decided to assess the
orientation of DiI-C20, another membrane probe known to
orient in ternary SPBs that mimic eukaryotic membranes
with its linear conjugated bridge at an average polar angle
of 70–75 (47). This tilt angle was reported to be dependent
on the cholesterol concentration and the phase state of the
bilayer. In this study, the pTIRFM order parameter for
DiI-C20 in intact 3:1 POPE/TOCL SPBs corresponded to a
tilt angle of 69.7, indicating that the bilayers existed in a
mainly fluid liquid-disordered phase state.
The addition of PR-9 to the SPBs led to rapid formation of
lipid domains, an effect observed by both AFM andTABLE 1 Summary of pTIRFM ﬂuorescent probe order parameter a
POPE/TOCL SLBs both before and after the addition of PR-9
Fluorescent Probe
Before PR-9 addition
(single topographical phase) (h
hP2i hqi hP2i
NAO 0.155 0.01 48.8 5 0.5 0.125
DiI-C20 0.325 0.01 69.7 5 0.5 0.245
All reported hP2i values are an average of at least 500 pixels from multiple regio
calculated by inverting Eq. 4.
Biophysical Journal 98(5) 815–823pTIRFM. The enhanced fluorescence intensity of NAO
was localized to the domains, as seen in the raw p- and
s-polarized pTIRFM images, suggesting that higher concen-
trations of TOCL were present in these regions. The exis-
tence of two distinct pTIRFM-determined order parameters
for NAO, as compared to the single value seen before
PR-9 addition, supports this claim. We found that, in the
TOCL-rich domains, the NAO order-parameter values corre-
sponded to a chromophore polar tilt angle of 50.0, whereas
in the surrounding lower topography regions, the angle was
47.6. The increased polar tilt-angle of NAO’s absorption
transition dipole moment in the lipid domains is consistent
with tight binding of NAO’s aromatic chromophore and
the headgroup gap caused by the lateral stacking of adjacent
cardiolipins in ordered rows, as has been reported by others
(see Figs. 2 and 3 in (77) and (92), respectively). We also
found that the polar tilt angle of DiI-C20’s chromophore
decreased to 65.4 and 63.9 in the domains and the
surrounding lower topography phase, respectively. This
result was consistent with an overall loss of lipid acyl-tail
orientational order. The observation that the DiI-C20 fluores-
cence intensity and average polar tilt angle were both greater
in the domain areas, as compared to the surrounding
membrane phase, is consistent with the known partitioning
of DiI-C20 into more ordered lipid phases (65,82). However,
because both tilt angles were lower than the single tilt angle
measured before PR-9 addition, the overall lipid acyl-chain
order was likely less in both phases compared to that of
normal non-phase-separated 3:1 POPE/TOCL SPBs. This
was consistent with the PR-9 peptide initiating clustering
of the lower-melting, more-fluid anionic TOCL component
into domains. This observation also agrees with the proposed
mechanism of action of PR-9 and similar AMPs. The
observed decrease in acyl-chain order may also explain
the appearance of the punctate topographical structures in
the AFM and pTIRFM images. These structures, which
also exhibit increased NAO and DiI-C20 fluorescence, could
be lipid vesicles emerging from the SPB because of the
decrease in membrane order and the onset of domain
boundary instabilities. In this study, one of the components
of the mixture is POPE, a lipid with high negative-curvature
tendencies. When phase separation occurs, the domains
enriched in POPE would have a tendency to form curved
structures that could facilitate the formation of punctate
structures and/or vesicle budding.nd absorption transition dipole polar tilt angles measured in 3:1
After PR-9 addition
igh topographical phase)
After PR-9 addition
(low topographical phase)
high hqihigh hP2ilow hqilow
0.01 50.0 5 0.5 0.185 0.02 47.6 5 1.0
0.01 65.4 5 0.5 0.215 0.01 63.9 5 0.3
ns of interest in three different identically prepared samples. hqi values are
FIGURE 4 Selected AFM images sequence of an unlabeled 3:1 POPE/
TOCL SPB before (A) and after (B) PR-9 is introduced into the imaging
chamber at a final concentration of 6.7 mg/mL. Scale bar ¼ 5 mm.
Peptide-Induced Domain Formation 821In contrast to our work with tetraoleoyl cardiolipin, recent
AFM studies of 4:1 POPE/beef-heart cardiolipin SPBs
reported evidence of domains at both room temperature
and 37C in the absence of any peptides (94–97). We also
observed domain formation in a separate set of experiments
using beef-heart cardiolipin (see Fig. S2). These observa-
tions argue that the cardiolipin source (and perhaps lipid
impurities therein) can influence membrane structure and
phase state. Beef-heart cardiolipin has predominantly poly-
unsaturated linoleoyl chains that are much more prone to
oxidation than the oleoyl chains of the synthetic cardiolipin
used in this work. Additionally, the 18:2 chains of beef-heart
cardiolipin are shorter than the 18:1 of the synthetic lipids
and hence less miscible with POPE. Interestingly, we found
that the addition of PR-9 at concentration (III0) in beef-heart
cardiolipin/POPE SPBs caused rapid and widespread
membrane destabilization and vesicle blebbing, indicating
that the presence of preexisting domain structures in themembrane may enhance the efficacy of the peptide in rear-
ranging the lipids (see Fig. S3).CONCLUSION
This study has provided the first direct evidence of antimicro-
bial peptide-induced domain formation in model membranes,
enabling us to assess the dynamics of domain formation,
including growth rates, peptide-induced restructuring, and
lipid recruitment. Our use of a powerful coupled AFM-
pTIRFM imaging approach to examine how these peptide-
membrane interactions led to changes in membrane order
portends its application in more detailed studies of complex
structural dynamics on both model and real cell membranes.SUPPORTING MATERIAL
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